Conversion Labs Appoints Former White House Physician and U.S. Navy Rear Admiral, Dr. Connie Mariano, to Board of Directors

Labs Appoints Former White House Physician and U.S. Navy Rear Admiral, Dr. Connie Mariano, to Board of Directors

YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) - Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and

wellness company, has appointed healthcare veteran, Dr. Connie Mariano, to its board of directors. Following her appointment,

the board will have eight members, with five serving independently.

certified in internal medicine, Dr. Mariano brings 30 years of executive leadership in healthcare to Conversion Labs. She will

advise company management on health care services and product development related to the company's telemedicine brands,

including Rex MD , Shapiro MD , SOS Rx , Veritas MD and others under development.

Mariano has been a pioneer in breaking down barriers and shattering glass ceilings, including becoming the first Filipino American

promoted to the rank of U.S. Navy Rear Admiral and the first military woman to be appointed White House Physician. She later became

director of the White House Medical Unit and served for nine years at the White House as physician to three sitting presidents.

phenomenal healthcare leader, Dr. Mariano brings to our board extensive knowledge and experience in providing the best in quality

health care," noted Justin Schreiber, chairman and CEO of Conversion Labs. "Her background in internal medicine and

concierge care represents a valuable addition to our board. We look forward to her insights and guidance as we continue to enhance

and expand our telehealth platform."

leaving the White House, Dr. Mariano became a consultant in the executive health program at the Mayo Clinic in Scottsdale, Arizona,

where she provided holistic health evaluations for senior executives. She later founded the Center for Executive Medicine,

a concierge medical practice that provides presidential-quality' care to CEOs and their families.

earned her bachelor's degree with honors from Revelle College at the University of California, San Diego. She received her

medical degree from the Uniformed Services University School of Medicine in Bethesda, Maryland, where she was commissioned as

a U.S. Navy lieutenant upon graduation.

Labs has earned a strong reputation of delivering quality, cutting-edge telehealth products and services, which is evident in

its strong customer growth over the past year," commented Dr. Mariano. "There is a growing need for telemedicine services

in today's post-COVID world, and I believe Conversion Labs is uniquely positioned to address this need. I look forward to

contributing my knowledge and experience to support Conversion Labs' growth in this very important field."

Labs has seen an acceleration in its operational and financial performance since the beginning of the year. The company recently

reported its annualized revenue run rate hit $46.8 million versus $12.5 million for all of 2019 - a more than three-fold

Labs, Inc. is a telemedicine company with a portfolio of online direct-to-consumer brands. The company's brands combine

virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians

offers telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. To learn more, visit Conversionlabs.com.

Cautions Regarding Forward-Looking Statements

news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E

of the Securities Exchange Act of 1934, as amended, regarding, among other things our plans, strategies and prospects -

both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these

forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations.

Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements

contained in this news release may be identified by the use of forward-looking words such as "believe," "expect,"

"anticipate," "should," "planned," "will," "may," "intend,"

"estimated," and "potential," among others. Important factors that could cause actual results to differ

materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports

or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements

attributable to Conversion Labs, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary

are the property of their respective owners.

Manuel Pi eiro Dagnery

and Investor Relations Contact